Table 2.
Point estimate and cumulative cancer risk for incremental polyp size with 99% credible intervals
Polyp size | Median risk | Polyp size | Median risk |
---|---|---|---|
5 mm | 0.14% (0.08–0.26%%) | 23 mm | 1.64% (0.79–3.25%) |
6 mm | 0.22% (0.12–0.42%%) | 24 mm | 1.70% (0.81–3.37%) |
7 mm | 0.31% (0.16–0.59%) | 25 mm | 1.76% (0.84–3.49%) |
8 mm | 0.41% (0.21–0.78%) | 26 mm | 1.82% (0.87–3.6%) |
9 mm | 0.51% (0.26–0.97%) | 27 mm | 1.87% (0.89–3.71%) |
10 mm | 0.60% (0.30–1.16%) | 28 mm | 1.92% (0.91–3.81%) |
11 mm | 0.70% (0.35–1.36%) | 29 mm | 1.97% (0.94–3.91%) |
12 mm | 0.80% (0.39–1.54%) | 30 mm | 2.02% (0.96–4.01%) |
13 mm | 0.89% (0.44–1.73%) | 31 mm | 2.07% (0.98–4.11%) |
14 mm | 0.98% (0.48–1.91%) | 32 mm | 2.11% (1.00–4.20%) |
15 mm | 1.06% (0.52–2.08%) | 33 mm | 2.16% (1.02–4.29%) |
16 mm | 1.14% (0.56–2.25%) | 34 mm | 2.20% (1.04–4.38%) |
17 mm | 1.22% (0.59–2.41%) | 35 mm | 2.24% (1.06–4.46%) |
18 mm | 1.30% (0.63–2.56%) | 36 mm | 2.28% (1.08–4.54%) |
19 mm | 1.37% (0.66–2.71%) | 37 mm | 2.32% (1.09–4.62%) |
20 mm | 1.44% (0.70–2.85%) | 38 mm | 2.36% (1.11–4.69%) |
21 mm | 1.51% (0.73–2.99%) | 39 mm | 2.39% (1.13–4.77%) |
22 mm | 1.58% (0.76–3.12%) | 40 mm | 2.43% (1.14–4.84%) |